Jump to main content
Jump to site search


Antifungal amphiphilic kanamycins: new life for an old drug

Author affiliations

Abstract

Classical aminoglycoside antibiotics are obsolete or hampered by the emergence of drug resistant bacteria. Recent discoveries of antifungal amphiphilic kanamycins offer new strategies for reviving and repurposing these old drugs. A simple structural modification turns the clinically obsolete antibacterial kanamycin into an antifungal agent. Structure–activity relationship studies have led to the production of K20, an antifungal kanamycin that can be mass-produced for uses in agriculture as well as in animals. This review delineates the path to the discovery of K20 and other related antifungal amphiphilic kanamycins, determination of its mode of action, and findings in greenhouse and field trials with K20 that could lead to crop disease protection strategies.

Graphical abstract: Antifungal amphiphilic kanamycins: new life for an old drug

Back to tab navigation

Publication details

The article was received on 21 Mar 2018, accepted on 15 Apr 2018 and first published on 17 Apr 2018


Article type: Review Article
DOI: 10.1039/C8MD00155C
Citation: Med. Chem. Commun., 2018, Advance Article
  •   Request permissions

    Antifungal amphiphilic kanamycins: new life for an old drug

    Y. P. Subedi, M. N. AlFindee, J. Y. Takemoto and C. T. Chang, Med. Chem. Commun., 2018, Advance Article , DOI: 10.1039/C8MD00155C

Search articles by author

Spotlight

Advertisements